Join Our Community:

Twitter  Linkedin  

Volume 03 Issue32

September 09, 2022

Because life depends on us™
BSMA Clearing House
for latest news and information
...at a glance
ORGANIZATION NEWS!

Australian CRO makes a move across the Pacific for US acquisition


Merck KGaA continues expansion with $285M+ investment in 2 new projects in France and Germany


Watch out Moderna: John Maraganore, ARCH and Beam are hatching a platform play 'to lead the future of RNA therapies'


Singapore sling: Catalent will invest $2.2M in clinical supply facility


AmerisourceBergen's $19.8M deal with U.S. will expand shipments and distribution network of monkeypox meds


Seeking first-in-class glory, Roche enlists biotech partner that prides itself on cracking 'undruggable' targets


Updated: EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case


Oxford Science Enterprises Raises £250 Million To Support University Innovations


Leading healthcare agency notches double-digit growth for first half, driven by digital shifts and full pipelines


Pfizer’s Idea Orchard

EXECUTIVE NEWS!

ArisGlobal Accelerates Growth, Announces Executive Evolution


Head of Global Healthcare Logistics Company CRYOPDP Wins Business Worldwide Magazine CEO Award


2022-PharmaVoice-100-List-of-Most-Inspiring-People-in-Life-Sciences


Trinity Life Sciences Announces the Appointment of Maia Germain as Chief People Officer


Jay Bradner’s NIBR exit sets off a succession plan at Merck; Dyne and MorphoSys fill major R&D roles


Pfizer reshuffles top leadership to hone commercial strategy, leaving room for new rare disease chief

The Editorial

Reducing Blind Spots in the Pharma Supply Chain


by Suzanne ShelleyPharmaceutical Technology


Expanded use of data analytics can help to avoid disruptions, but the possibilities cannot be realized without sufficient investment and direct human involvement.


It has become painfully clear in recent years that potential supply chain disruptions across all industries have become more the rule than the exception. Such disruptions arise when manufacturers experience short-term or prolonged shortages in raw materials, packaging materials, and/or critical components and are then unable to produce a reliable output of finished products or deliver them on time to their own downstream customers.

For pharma manufacturers, such issues increase business risk, create unnecessary costs and product losses, and increase the likelihood of


Read more...

INNOVATIONS!

Owkin AI for identifying breast, colorectal cancer types score EU approval


Healthcare Executives Concerned About Supply Chain Issues, Cyberattacks


The Digital Innovations Behind The Booming Life Sciences Industry


Life science innovation drives Triangle economy and demand for world-class space


Digital Solutions, Technology, And Patient Care Top Life Science Trends


Exploring Options for Optimizing Cell Line Development

INFRASTRACTURE

Federal Investments in K-12 Infrastructure Would Benefit Students Across the Country


The Lost Opportunity in Biden’s Big Infrastructure Bills


State Learning Lab On Energy And Critical Infrastructure Resilience


U.S. Infrastructure Is Due For An Upgrade To Withstand Extreme Weather


Here are 3 major policy areas that health industry groups are closely watching in $3.5T infrastruture bill


CHALLENGES & SOLUTIONS!

Pharma and healthcare digital ad spending slows after pandemic increase, but still headed for $20B — report


DHL Bolsters Talent Acquisition Through Education Work


The price of grain, the global supply chain, and the invasion of Ukraine


How to Make the Most of Your Life Science Internship


Forging political alliances through supply chains


Small and Medium Biotech Companies Still Growing in Uncertain Times


Six challenges to delivering quality healthcare


Liz Truss must value science, not fear it


Inventory Management Strategy - Play Chess, Not Battlefield


How tech companies can stay agile in an uncertain world


Testing, Inspection, and Certification for Life Sciences Market Size & Analysis By 2022


ADRA Faces the Global Hunger Crisis


Looking beyond global supply chains


PhRMA and BIO seek changes in FDA’s guidance to mitigate drug shortages


Too little too late: TRIPS waiver saga illustrates global policy hesitancy


Securing Biodiversity Net Gain on Logistics Sites


How biopharmaceutical manufacturing has changed in the post-pandemic era: Re-analyzing cost benefit vs. quality benefits

UPCOMING EVENTS:

~~~~~~~

BSMA Europe
In-Person Summit:
September 29, 2022

LOCATION:
Brussels, La Hulpe, Belgium




~~~~~~~

BSMA Africa Inaugural
In-Person Summit:
Oct. 31-Nov. 1, 2022

LOCATION:
Kigali, Rwanda
Editor:
Devendra Mishra
Executive Director & Co-Founder
BSMA
+1-818-224-1552
Editor:
Dotti Yells
VP, Marketing Technology
BSMA